anmelden
SXI Life Sciences
7.772,36
PKT
-3,32
PKT
-0,04
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Leider sind zu diesem Wert keine aktuellen Kursdaten verfügbar, die Stammdaten finden Sie im unteren Seitenbereich.
Analysen zu SXI Life Sciences-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 09.06.23 | Novartis Buy | Jefferies & Company Inc. | |
| 08.06.23 | Roche Hold | Jefferies & Company Inc. | |
| 06.06.23 | Novartis Buy | Deutsche Bank AG | |
| 05.06.23 | Novartis Neutral | UBS AG | |
| 05.06.23 | Roche Equal Weight | Barclays Capital | |
| 05.06.23 | Novartis Buy | Deutsche Bank AG | |
| 05.06.23 | Novartis Underweight | Barclays Capital | |
| 05.06.23 | Roche Underweight | JP Morgan Chase & Co. | |
| 02.06.23 | Novartis Buy | Jefferies & Company Inc. | |
| 30.05.23 | Roche Sell | Deutsche Bank AG | |
| 26.05.23 | Roche Underweight | JP Morgan Chase & Co. | |
| 24.05.23 | Roche Sell | Deutsche Bank AG | |
| 24.05.23 | Roche Equal Weight | Barclays Capital | |
| 19.05.23 | Novartis Neutral | JP Morgan Chase & Co. | |
| 18.05.23 | Novartis Neutral | UBS AG | |
| 02.05.23 | Novartis Buy | Jefferies & Company Inc. | |
| 28.04.23 | Roche Sell | Deutsche Bank AG | |
| 27.04.23 | Roche Outperform | Credit Suisse Group | |
| 27.04.23 | Roche Sell | Deutsche Bank AG | |
| 27.04.23 | Roche Underweight | JP Morgan Chase & Co. | |
| 26.04.23 | Novartis Underperform | Credit Suisse Group | |
| 26.04.23 | Novartis Underweight | Barclays Capital | |
| 26.04.23 | Novartis Neutral | JP Morgan Chase & Co. | |
| 26.04.23 | Roche Underweight | JP Morgan Chase & Co. | |
| 26.04.23 | Novartis Buy | Deutsche Bank AG | |
| 26.04.23 | Roche Hold | Jefferies & Company Inc. | |
| 25.04.23 | Novartis Buy | Jefferies & Company Inc. | |
| 21.04.23 | Roche Sell | Deutsche Bank AG | |
| 18.04.23 | Roche Hold | Jefferies & Company Inc. | |
| 18.04.23 | Novartis Buy | Jefferies & Company Inc. | |
| 17.04.23 | Roche Underweight | JP Morgan Chase & Co. | |
| 12.04.23 | Novartis Neutral | JP Morgan Chase & Co. | |
| 11.04.23 | Novartis Underweight | Barclays Capital | |
| 11.04.23 | Roche Underweight | JP Morgan Chase & Co. | |
| 05.04.23 | Roche Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 29.03.23 | Roche Underweight | JP Morgan Chase & Co. | |
| 28.03.23 | Novartis Neutral | UBS AG | |
| 28.03.23 | Novartis Hold | Deutsche Bank AG | |
| 27.03.23 | Roche Equal Weight | Barclays Capital | |
| 27.03.23 | Novartis Buy | Jefferies & Company Inc. |
